Riskpilot← Back to searchSign inGet full accessAddbio AB
ABIn liquidationOrg 5567550982Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20083 employees
Revenue 2022
SEK 30K
EBITDA margin
-8650.0%
-61% vs 2021
Equity ratio
9.2%
Financial strength
Net profit 2022
SEK -67,9M
-3448% vs 2021
| Revenue | SEK 30K | — |
| EBITDA | SEK -2,6M | -61% |
| Net profit | SEK -67,9M | -3448% |
| Total assets | SEK 5,3M | -92% |
| Equity | SEK 484K | -99% |
| Employees | 3 | — |
Legal name
Addbio AB
Org number
5567550982
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
3 april 2008
Share capital
SEK 13 320 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget ska bedriva affärsutvecklingsverksamhet med syfte att kommersialisera innovationer inom hälso- och sjukvårdsområdet och därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 70 | 0 | 0 | 0 | 30 |
| Staff expenses | — | — | — | — | — | — | — | — |
| EBITDA | −2 928 | −2 416 | −3 064 | −2 952 | −3 450 | −6 521 | −1 607 | −2 595 |
| Depreciation & amort. | −814 | −16 | −44 | −106 | −118 | −127 | −127 | −65 131 |
| EBIT | −3 742 | −2 432 | −3 108 | −3 058 | −3 568 | −6 648 | −1 734 | −67 726 |
| Net financials | −15 | −130 | −255 | −212 | −155 | −140 | −180 | −177 |
| Profit before tax | −3 757 | −2 561 | −3 363 | −3 270 | −3 723 | −6 788 | −1 914 | −67 903 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −3 757 | −2 561 | −3 363 | −3 270 | −3 723 | −6 788 | −1 914 | −67 903 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 29 164 | 39 234 | 43 630 | 53 745 | 58 599 | 66 217 | 68 524 | 5 287 |
| Equity | 27 702 | 32 578 | 35 802 | 40 500 | 51 136 | 61 301 | 63 387 | 484 |
| Long-term debt | 485 | 5 125 | 3 497 | 10 430 | 972 | 2 021 | 1 836 | 0 |
| Short-term debt | 977 | 1 531 | 4 332 | 2 814 | 6 491 | 2 895 | 3 302 | 4 803 |
| Total debt | 1 462 | 6 656 | 7 829 | 13 244 | 7 463 | 4 916 | 5 138 | 4 803 |
EBITDA margin
-8650.0%
This company
15.8%
Market median
-54847% vs market
20152022
Equity ratio
9.2%
This company
38.2%
Market median
-76% vs market
20152022
Return on equity
-14029.5%
This company
18.4%
Market median
-76347% vs market
20152022
Net profit margin
-226343.3%
This company
8.1%
Market median
-2794462% vs market
20152022
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20152022
Debt / equity
9.92×
This company
0.62×
Market median
-1500% vs market
20152022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KJ Chief Auditor | Chief Auditor | 2020 | — | — |
GL Liquidator | Liquidator | 2023 | — | — |
UR Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Addbio AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kurt Jörgen Lövgren | Chief Auditor | 0 companies |
| Gunnar Lars-Olof Svensson | Liquidator | 0 companies |
| Ulf Ragnar Severin | Chief Executive Officer | 0 companies |
| Lars Erik Henriksson | Board of Directors | 0 companies |
| Pär Olov Östman | Board of Directors | 0 companies |
| Gunilla Ingeborg O Lundmark | Board of Directors | 0 companies |
| Peter Sellei | Board of Directors | 0 companies |
| Anders Henrik Weilandt | Chairman | 0 companies |
| Michael Sven Rohmann | Board of Directors | 0 companies |
| Rolf Tommy Johansson | Chairman | 0 companies |
| Nils Henrik Milton Rammer | Board of Directors | 0 companies |